-
Something wrong with this record ?
Revealed heterogeneity in rheumatoid arthritis based on multivariate innate signature analysis
A. Petrackova, P. Horak, M. Radvansky, R. Fillerova, V. Smotkova Kraiczova, M. Kudelka, F. Mrazek, M. Skacelova, A. Smrzova, E. Kriegova,
Language English Country Italy
Document type Journal Article
NLK
Free Medical Journals
from 1999 to 5 years ago
Freely Accessible Science Journals
from 1999 to 4 years ago
PubMed
31376255
Knihovny.cz E-resources
- MeSH
- Interferon Type I * immunology MeSH
- Leukocytes, Mononuclear MeSH
- Humans MeSH
- Multivariate Analysis MeSH
- Arthritis, Rheumatoid * genetics immunology metabolism MeSH
- Toll-Like Receptors * genetics immunology metabolism MeSH
- Transcriptome MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
OBJECTIVES: A growing body of evidence highlights the persistent activation of the innate immune system and type I interferon (IFN) signature in the pathogenesis of rheumatoid arthritis (RA) and its association with disease activity. Since the recent study revealed heterogeneity in the IFN signature in RA, we investigated for the first time the heterogeneity in innate signature in RA. METHODS: The innate gene expression signature (10 TLRs, 7 IL1/IL1R family members, and CXCL8/IL8) was assessed in peripheral blood mononuclear cells from RA patients (n=67), both with active (DAS28≥3.2, n=32) and inactive disease (DAS28<3.2, n=35), and in healthy control subjects (n=55). RESULTS: Of the 13 deregulated innate genes (TLR2, TLR3, TLR4, TLR5, TLR8, TLR10, IL1B, IL1RN, IL18, IL18R1, IL1RAP, and SIGIRR/IL1R8) associated with RA, TLR10 and IL1RAP are being reported for the first time. Multivariate analysis based on utilising patient similarity networks revealed the existence of four patient's subsets (clusters) based on different TLR8 and IL1RN expression profiles, two in active and two in inactive RA. Moreover, neural network analysis identified two main gene sets describing active RA within an activity-related innate signature (TLR1, TLR2, TLR3, TLR7, TLR8, CXCL8/IL8, IL1RN, IL18R1). When comparing active and inactive RA, upregulated TLR2, TLR4, TLR6, and TLR8 and downregulated TLR10 (P<0.04) expression was associated with the disease activity. CONCLUSIONS: Our study on the comprehensive innate gene profiling together with multivariate analysis revealed a certain heterogeneity in innate signature within RA patients. Whether the heterogeneity of RA elucidated from diversity in innate signatures may impact the disease course and treatment response deserves future investigations.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023128
- 003
- CZ-PrNML
- 005
- 20201214125330.0
- 007
- ta
- 008
- 201125s2020 it f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)31376255
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Petrackova, Anna $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic.
- 245 10
- $a Revealed heterogeneity in rheumatoid arthritis based on multivariate innate signature analysis / $c A. Petrackova, P. Horak, M. Radvansky, R. Fillerova, V. Smotkova Kraiczova, M. Kudelka, F. Mrazek, M. Skacelova, A. Smrzova, E. Kriegova,
- 520 9_
- $a OBJECTIVES: A growing body of evidence highlights the persistent activation of the innate immune system and type I interferon (IFN) signature in the pathogenesis of rheumatoid arthritis (RA) and its association with disease activity. Since the recent study revealed heterogeneity in the IFN signature in RA, we investigated for the first time the heterogeneity in innate signature in RA. METHODS: The innate gene expression signature (10 TLRs, 7 IL1/IL1R family members, and CXCL8/IL8) was assessed in peripheral blood mononuclear cells from RA patients (n=67), both with active (DAS28≥3.2, n=32) and inactive disease (DAS28<3.2, n=35), and in healthy control subjects (n=55). RESULTS: Of the 13 deregulated innate genes (TLR2, TLR3, TLR4, TLR5, TLR8, TLR10, IL1B, IL1RN, IL18, IL18R1, IL1RAP, and SIGIRR/IL1R8) associated with RA, TLR10 and IL1RAP are being reported for the first time. Multivariate analysis based on utilising patient similarity networks revealed the existence of four patient's subsets (clusters) based on different TLR8 and IL1RN expression profiles, two in active and two in inactive RA. Moreover, neural network analysis identified two main gene sets describing active RA within an activity-related innate signature (TLR1, TLR2, TLR3, TLR7, TLR8, CXCL8/IL8, IL1RN, IL18R1). When comparing active and inactive RA, upregulated TLR2, TLR4, TLR6, and TLR8 and downregulated TLR10 (P<0.04) expression was associated with the disease activity. CONCLUSIONS: Our study on the comprehensive innate gene profiling together with multivariate analysis revealed a certain heterogeneity in innate signature within RA patients. Whether the heterogeneity of RA elucidated from diversity in innate signatures may impact the disease course and treatment response deserves future investigations.
- 650 12
- $a revmatoidní artritida $x genetika $x imunologie $x metabolismus $7 D001172
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a interferon typ I $x imunologie $7 D007370
- 650 _2
- $a leukocyty mononukleární $7 D007963
- 650 _2
- $a multivariační analýza $7 D015999
- 650 12
- $a toll-like receptory $x genetika $x imunologie $x metabolismus $7 D051193
- 650 _2
- $a transkriptom $7 D059467
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Horak, Pavel $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic.
- 700 1_
- $a Radvansky, Martin $u Department of Computer Science, Faculty of Electrical Engineering and Computer Science, Technical University of Ostrava, Czech Republic.
- 700 1_
- $a Fillerova, Regina $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic.
- 700 1_
- $a Smotkova Kraiczova, Veronika $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic.
- 700 1_
- $a Kudelka, Milos $u Department of Computer Science, Faculty of Electrical Engineering and Computer Science, Technical University of Ostrava, Czech Republic.
- 700 1_
- $a Mrazek, Frantisek $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic.
- 700 1_
- $a Skacelova, Martina $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic.
- 700 1_
- $a Smrzova, Andrea $u Department of Internal Medicine III - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic.
- 700 1_
- $a Kriegova, Eva $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic. eva.kriegova@email.cz.
- 773 0_
- $w MED00001116 $t Clinical and experimental rheumatology $x 0392-856X $g Roč. 38, č. 2 (2020), s. 289-298
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31376255 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214125330 $b ABA008
- 999 __
- $a ok $b bmc $g 1595447 $s 1113804
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 38 $c 2 $d 289-298 $e 20190803 $i 0392-856X $m Clinical and Experimental Rheumatology $n Clin Exp Rheumatol $x MED00001116
- LZP __
- $a Pubmed-20201125